Phase II Study of Docetaxel, Nedaplatin, and 5-Fluorouracil Combined Chemotherapy for Advanced Esophageal Cancer

被引：0
|
作者：
Tatsuya Miyazaki
Hitoshi Ojima
Minoru Fukuchi
Makoto Sakai
Makoto Sohda
Naritaka Tanaka
Shigemasa Suzuki
Keisuke Ieta
Kana Saito
Akihiko Sano
Takehiko Yokobori
Takanori Inose
Masanobu Nakajima
Hiroyuki Kato
Hiroyuki Kuwano
机构：
[1] Gunma University Graduate School,Department of General Surgical Science (Surgery 1)
[2] Gunma Prefectural Cancer Center,Department of Gastroenterological Surgery
[3] Gunma Chuo Hospital,Department of Surgery
[4] Isesaki Municipal Hospital,Department of Surgery
[5] Dokkyo Medical University,Department of Surgery I
来源：
Annals of Surgical Oncology | 2015年 / 22卷
关键词：
Docetaxel; Esophageal Cancer; Acute Kidney Injury; CDDP; Complete Response Rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3653 / 3658
页数：5
相关论文
共 50 条
  • [1] Phase II Study of Docetaxel, Nedaplatin, and 5-Fluorouracil Combined Chemotherapy for Advanced Esophageal Cancer
    Miyazaki, Tatsuya
    Ojima, Hitoshi
    Fukuchi, Minoru
    Sakai, Makoto
    Sohda, Makoto
    Tanaka, Naritaka
    Suzuki, Shigemasa
    Ieta, Keisuke
    Saito, Kana
    Sano, Akihiko
    Yokobori, Takehiko
    Inose, Takanori
    Nakajima, Masanobu
    Kato, Hiroyuki
    Kuwano, Hiroyuki
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (11) : 3653 - 3658
  • [2] Effectiveness of Combination Chemotherapy With Docetaxel, Nedaplatin, and 5-Fluorouracil for Advanced and Recurrent Esophageal Cancer
    Sohda, Makoto
    Hara, Keigo
    Kuriyama, Kengo
    Tateno, Kouhei
    Uchida, Shintaro
    Watanabe, Takayoshi
    Shibasaki, Yuta
    Saito, Hideyuki
    Nakazawa, Nobuhiro
    Sano, Akihiko
    Sakai, Makoto
    Yokobori, Takehiko
    Ogawa, Hiroomi
    Shirabe, Ken
    Saeki, Hiroshi
    ANTICANCER RESEARCH, 2024, 44 (03) : 1309 - 1315
  • [3] Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer
    Miyazaki, Tatsuya
    Sohda, Makoto
    Tanaka, Naritaka
    Suzuki, Shigemasa
    Ieta, Keisuke
    Sakai, Makoto
    Sano, Akihiko
    Yokobori, Takehiko
    Inose, Takanori
    Nakajima, Masanobu
    Fukuchi, Minoru
    Ojima, Hitoshi
    Kato, Hiroyuki
    Kuwano, Hiroyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 853 - 857
  • [4] Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer
    Tatsuya Miyazaki
    Makoto Sohda
    Naritaka Tanaka
    Shigemasa Suzuki
    Keisuke Ieta
    Makoto Sakai
    Akihiko Sano
    Takehiko Yokobori
    Takanori Inose
    Masanobu Nakajima
    Minoru Fukuchi
    Hitoshi Ojima
    Hiroyuki Kato
    Hiroyuki Kuwano
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 853 - 857
  • [5] Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study
    Ohnuma, Hiroyuki
    Sato, Yasushi
    Hayasaka, Naotaka
    Matsuno, Teppei
    Fujita, Chisa
    Sato, Masanori
    Osuga, Takahiro
    Hirakawa, Masahiro
    Miyanishi, Koji
    Sagawa, Tamotsu
    Fujikawa, Koshi
    Ohi, Motoh
    Okagawa, Yutaka
    Tsuji, Yasushi
    Hirayama, Michiaki
    Ito, Tatsuya
    Nobuoka, Takayuki
    Takemasa, Ichiro
    Kobune, Masayoshi
    Kato, Junji
    CANCER SCIENCE, 2018, 109 (11): : 3554 - 3563
  • [6] A phase I/II study of definitive chemoradiotherapy with docetaxel, nedaplatin, and 5-fluorouracil (DNF-R) for advanced esophageal cancer
    Sato, Yasushi
    Ohnuma, Hiroyuki
    Hirakawa, Masahiro
    Okagawa, Yutaka
    Osuga, Takahiro
    Murase, Kazuyuki
    Takada, Kohichi
    Kawano, Yutaka
    Iyama, Satoshi
    Hayashi, Tsuyoshi
    Sato, Tsutomu
    Miyanishi, Koji
    Takimoto, Rishu
    Kobune, Masayoshi
    Sagawa, Tamotsu
    Hori, Masakazu
    Someya, Masanori
    Sakata, Koh-ichi
    Takayama, Tetsuji
    Kato, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [7] Phase II Study of Docetaxel and Cisplatin Chemotherapy in 5-Fluorouracil/Cisplatin Pretreated Esophageal Cancer
    Shim, Hyun-Jeong
    Cho, Sang-Hee
    Hwang, Jun-Eul
    Bae, Woo-Kyun
    Song, Sang-Yun
    Cho, Sung-Bum
    Lee, Wan-Sik
    Joo, Young-Eun
    Na, Kook-Joo
    Chung, Ik-Joo
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (06): : 624 - 628
  • [8] Evaluation of combined docetaxel and nedaplatin chemotherapy for recurrent esophageal cancer compared with conventional chemotherapy using cisplatin and 5-fluorouracil: a retrospective study
    Fujita, Y.
    Hiramatsu, M.
    Kawai, M.
    Sumiyoshi, K.
    Nishimura, H.
    Tanigawa, N.
    DISEASES OF THE ESOPHAGUS, 2008, 21 (06): : 496 - 501
  • [9] Phase II Trial of 5-Fluorouracil, Docetaxel, and Nedaplatin (UDON) Combination Therapy for Recurrent or Metastatic Esophageal Cancer
    Ueda, Hiroto
    Kawakami, Hisato
    Nonagase, Yoshikane
    Takegawa, Naoki
    Okuno, Tatsuya
    Takahama, Takayuki
    Takeda, Masayuki
    Chiba, Yasutaka
    Tamura, Takao
    Nakagawa, Kazuhiko
    ONCOLOGIST, 2019, 24 (02): : 163 - +
  • [10] Phase I study of the combination of nedaplatin, adriamycin and 5-fluorouracil for treatment of advanced esophageal cancer
    Hirao, M
    Fujitani, K
    Tsujinaka, T
    DISEASES OF THE ESOPHAGUS, 2004, 17 (03) : 247 - 250
12345